These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 33086324)
1. Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma. Crippa S; Pergolini I; Javed AA; Honselmann KC; Weiss MJ; Di Salvo F; Burkhart R; Zamboni G; Belfiori G; Ferrone CR; Rubini C; Yu J; Gasparini G; Qadan M; He J; Lillemoe KD; Castillo CF; Wolfgang CL; Falconi M Ann Surg; 2022 Aug; 276(2):378-385. PubMed ID: 33086324 [TBL] [Abstract][Full Text] [Related]
2. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma. Nakagawa S; Yamashita YI; Umezaki N; Yamao T; Okabe H; Imai K; Nitta H; Hashimoto D; Chikamoto A; Baba H Pancreas; 2018 Oct; 47(9):1130-1134. PubMed ID: 30161074 [TBL] [Abstract][Full Text] [Related]
3. Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system. Schiavo Lena M; Gasparini G; Crippa S; Belfiori G; Aleotti F; Di Salvo F; Redegalli M; Cangi MG; Taveggia C; Falconi M; Doglioni C Virchows Arch; 2023 Aug; 483(2):225-235. PubMed ID: 37291275 [TBL] [Abstract][Full Text] [Related]
4. Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients. Nozzoli F; Catalano M; Messerini L; Cianchi F; Nassini R; De Logu F; Iannone LF; Ugolini F; Simi S; Massi D; Geppetti P; Roviello G Pancreatology; 2024 Jun; 24(4):553-561. PubMed ID: 38514359 [TBL] [Abstract][Full Text] [Related]
5. Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer. Zhang JF; Hua R; Sun YW; Liu W; Huo YM; Liu DJ; Li J Asian Pac J Cancer Prev; 2013; 14(9):5133-9. PubMed ID: 24175789 [TBL] [Abstract][Full Text] [Related]
7. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma. Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival. Belfiori G; Crippa S; Francesca A; Pagnanelli M; Tamburrino D; Gasparini G; Partelli S; Andreasi V; Rubini C; Zamboni G; Falconi M Ann Surg Oncol; 2021 Dec; 28(13):8249-8260. PubMed ID: 34258720 [TBL] [Abstract][Full Text] [Related]
9. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Chatterjee D; Katz MH; Rashid A; Wang H; Iuga AC; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Crane CH; Gomez HF; Abbruzzese JL; Fleming JB; Wang H Am J Surg Pathol; 2012 Mar; 36(3):409-17. PubMed ID: 22301497 [TBL] [Abstract][Full Text] [Related]
10. Resected pancreatic adenocarcinoma: An Asian institution's experience. Ng KYY; Chow EWX; Jiang B; Lim C; Goh BKP; Lee SY; Teo JY; Tan DMY; Cheow PC; Ooi LLPJ; Chow PKH; Lee JJX; Kam JH; Koh YX; Jeyaraj PR; Tan EK; Choo SP; Chan CY; Chung AYF; Tai D Cancer Rep (Hoboken); 2021 Oct; 4(5):e1393. PubMed ID: 33939335 [TBL] [Abstract][Full Text] [Related]
11. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection. Cha DE; Yu AT; Khajoueinejad N; Gleeson E; Shaltiel T; Berger Y; Macfie R; Golas BJ; Sarpel U; Labow DM; Hiotis S; Cohen NA World J Surg; 2023 Jul; 47(7):1801-1808. PubMed ID: 37014430 [TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9. Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma. Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790 [No Abstract] [Full Text] [Related]
14. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign? Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782 [TBL] [Abstract][Full Text] [Related]
15. Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition". Belfiori G; Crippa S; Pagnanelli M; Gasparini G; Aleotti F; Camisa PR; Partelli S; Pecorelli N; De Stefano F; Schiavo Lena M; Palumbo D; Tamburrino D; Reni M; Falconi M Ann Surg Oncol; 2024 Jun; 31(6):4084-4095. PubMed ID: 38459416 [TBL] [Abstract][Full Text] [Related]
16. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579 [TBL] [Abstract][Full Text] [Related]
17. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284 [TBL] [Abstract][Full Text] [Related]
18. Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis. Kim JK; DePeralta DK; Ogami T; Denbo JW; Pimiento J; Hodul PJ; Malafa MP; Kim DW; Fleming JB; Powers BD J Surg Oncol; 2020 Nov; 122(6):1074-1083. PubMed ID: 32673436 [TBL] [Abstract][Full Text] [Related]
19. Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study. van Goor IWJM; Schouten TJ; Verburg DN; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; Cirkel GA; van Dam RM; Festen S; Koerkamp BG; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; Los M; Meijer GJ; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Verdonk RC; van Santvoort HC; Daamen LA; Molenaar IQ; Ann Surg; 2024 Jan; 279(1):132-137. PubMed ID: 37450706 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma. Igarashi Y; Shirai Y; Tanji Y; Hamura R; Yanagaki M; Abe K; Onda S; Furukawa K; Matsumoto M; Tsunematsu M; Ikegami T Am Surg; 2023 Nov; 89(11):4255-4261. PubMed ID: 37776159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]